Ruben Mesa, MD Discusses Myelofibrosis

Ruben Mesa, MD

At the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Rare Disease Report sat down with Ruben Mesa, MD of the Mayo Clinic to discuss myelofibrosis pathophysiology, supportive care - like yoga and exercise - for patients, and his study evaluating the combination of ruxolitinib and momelotinib.

Among the questions asked were:
For more from ASCO, check out our Conference Coverage page.
Printer Printing...